SMIM2-IT1: A Drug Target / Disease Biomarker (G100874377)

Target Name: SMIM2-IT1

NCBI ID: G100874377

SMIM2-IT1

Other Name(s): SMIM2 intronic transcript 1 | C13orf44-IT1

SMIM2-IT1: A Drug Target / Disease Biomarker

SMIM2-IT1 is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the IMP (inositol-requiring protein) family, which includes proteins that are involved in intracellular signaling. SMIM2-IT1 has been shown to play a role in the regulation of a variety of cellular processes, including inflammation, stress, and metabolism.

SMIM2-IT1 is also of interest as a potential drug target. Its unique structure and function have led scientists to believe that it may be a useful target for new therapies. One approach that researchers have taken to study SMIM2-IT1 is to use RNA interference (RNAi) to knockdown the expression of the protein in cells. This has allowed researchers to study its effects on cellular processes and determine how it contributes to the normal functioning of different tissues.

In addition to its potential as a drug target, SMIM2-IT1 has also been shown to be a valuable biomarker for a variety of diseases. Its expression has been observed in a number of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. This suggests that it may be a useful indicator of the severity or progression of these diseases.

SMIM2-IT1 is also of interest as a potential therapeutic target for treating certain cardiovascular diseases. Studies have shown that SMIM2-IT1 is expressed in the hearts of individuals with certain cardiovascular conditions, including heart failure and hypertension. By targeting the expression of SMIM2-IT1, researchers may be able to develop new treatments for these conditions.

In conclusion, SMIM2-IT1 is a protein that has significant potential as a drug target and biomarker. Its unique structure and function make it an attractive target for researchers to study, and its expression in a variety of tissues makes it a valuable tool for the study of disease. Further research is needed to fully understand the role of SMIM2-IT1 in cellular processes and its potential as a therapeutic target.

Protein Name: SMIM2 Intronic Transcript 1

The "SMIM2-IT1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SMIM2-IT1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets